GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Pretax Margin %

Starton Therapeutics (Starton Therapeutics) Pretax Margin % : % (As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Starton Therapeutics's Pre-Tax Income for the three months ended in Jun. 2023 was $-3.05 Mil. Starton Therapeutics's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Starton Therapeutics's pretax margin for the quarter that ended in Jun. 2023 was %.

The historical rank and industry rank for Starton Therapeutics's Pretax Margin % or its related term are showing as below:


STA's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -155.98
* Ranked among companies with meaningful Pretax Margin % only.

Starton Therapeutics Pretax Margin % Historical Data

The historical data trend for Starton Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Pretax Margin % Chart

Starton Therapeutics Annual Data
Trend Mar21 Mar22 Mar23
Pretax Margin %
- -477.00 -

Starton Therapeutics Quarterly Data
Mar21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23
Pretax Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Starton Therapeutics's Pretax Margin %

For the Biotechnology subindustry, Starton Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Starton Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starton Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Starton Therapeutics's Pretax Margin % falls into.



Starton Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Starton Therapeutics's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-9.993/0
= %

Starton Therapeutics's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-3.049/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Starton Therapeutics  (NAS:STA) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Starton Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Starton Therapeutics (Starton Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
215 College Road, Suite No.300, Paramus, NJ, USA, 07652
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines